Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.
Redondo S, García-Cadenas I, Vila A, Esquirol A, Portos JM, Novelli S, Saavedra S, Moreno C, Garrido A, Arguello-Tomas M, Oñate G, López-Pardo J, Caballero AC, Miqueleiz S, Briones J, Sierra J, Sancho G, Martino R. Redondo S, et al. Among authors: portos jm. Eur J Haematol. 2023 Jul;111(1):146-153. doi: 10.1111/ejh.13978. Epub 2023 Apr 14. Eur J Haematol. 2023. PMID: 37058419
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature.
García-Cadenas I, Redondo S, Esquirol A, Portos JM, Novelli S, Saavedra S, Moreno C, Garrido A, Oñate G, López J, Caballero AC, Miqueleiz S, Arguello-Tomas M, Briones J, Sierra J, Martino R. García-Cadenas I, et al. Among authors: portos jm. Transplant Cell Ther. 2023 Jul;29(7):473.e1-473.e6. doi: 10.1016/j.jtct.2023.04.008. Epub 2023 Apr 20. Transplant Cell Ther. 2023. PMID: 37086849 Free article. Review.
Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement.
Moreno-Martinez ME, Riba M, García-Cadenas I, Esquirol A, Yusta M, Redondo S, De Dios A, Portos JM, Aso O, Marcos-Fendian A, Font N, Briones J, Martino R, Feliu A. Moreno-Martinez ME, et al. Among authors: portos jm. Front Immunol. 2024 Jun 11;15:1397115. doi: 10.3389/fimmu.2024.1397115. eCollection 2024. Front Immunol. 2024. PMID: 38919607 Free PMC article.
Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation.
Redondo S, García-Cadenas I, Esquirol A, Portos JM, Iranzo E, Arguello-Tomas M, Saavedra S, Oñate G, Caballero AC, Garrido A, López J, Muntañola A, Paviglianiti A, Miqueleiz S, Sierra J, Briones J, Martino R. Redondo S, et al. Among authors: portos jm. Eur J Haematol. 2024 Dec;113(6):776-787. doi: 10.1111/ejh.14294. Epub 2024 Aug 18. Eur J Haematol. 2024. PMID: 39155459
Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience.
Fernandez-Sojo J, Valdivia E, Esquirol A, Portos JM, Rovira M, Suarez M, Diaz-de-Heredia C, Uría ML, Ortí G, Ferra C, Mussetti A, Paviglianiti A, Marsal J, Badell I, Lozano M, Gomez D, Azqueta C, Martorell L, Rubio N, Garcia-Buendia A, Villa J, Carreras E, Querol S. Fernandez-Sojo J, et al. Among authors: portos jm. Vox Sang. 2023 Sep;118(9):783-789. doi: 10.1111/vox.13499. Epub 2023 Aug 2. Vox Sang. 2023. PMID: 37533171
11 results